Breaking News Instant updates and real-time market news.

2020-12-04 09:03:54 ST Sensata $48.82 / -0.235 (-0.48%) , CARR Carrier Global $36.70 / -0.125 (-0.34%) 09:03 12/04/20 12/04 09:03 12/04/20 09:03	Sensata signs strategic long-term agreement with Carrier Global Carrier Global (CARR) is proud to announce that Sensata Technologies(ST) has joined the Carrier Alliance program and signed a strategic long-term agreement with Carrier. Sensata will supply a range of sensors and controls across Carrier's HVAC and Refrigeration portfolios. Sensata sensors and controls are IoT-enabled and offer enhanced digital insights and connectivity, helping to improve overall system performance. ST Sensata $48.82 / -0.235 (-0.48%) CARR Carrier Global $36.70 / -0.125 (-0.34%)
ST CARR ST Sensata $48.82 / -0.235 (-0.48%) 10/22/20 Barclays Sensata price target raised to $55 from $49 at Barclays 10/19/20 Baird Sensata initiated with an Outperform at Baird 10/06/20 Berenberg Sensata initiated with a Buy at Berenberg 10/05/20 Fly Intel: Top five analyst upgrades CARR Carrier Global $36.70 / -0.125 (-0.34%) 11/30/20 Barclays Carrier Global price target raised to $45 from $38 at Barclays 11/18/20 KeyBanc Carrier Global price target raised to $47 from $42 at KeyBanc 10/15/20 Stephens Carrier Global initiated with an Overweight at Stephens 10/13/20 Fly Intel: Top five analyst initiations

2020-12-04 09:03:54

Sensata

$48.82 / -0.235 (-0.48%)

, CARR

Carrier Global

$36.70 / -0.125 (-0.34%)

09:03

12/04/20

12/04

09:03

12/04/20

09:03

Sensata signs strategic long-term agreement with Carrier Global

Carrier Global (CARR) is proud to announce that Sensata Technologies(ST) has joined the Carrier Alliance program and signed a strategic long-term agreement with Carrier. Sensata will supply a range of sensors and controls across Carrier's HVAC and Refrigeration portfolios. Sensata sensors and controls are IoT-enabled and offer enhanced digital insights and connectivity, helping to improve overall system performance.

Sensata

$48.82 / -0.235 (-0.48%)

CARR

Carrier Global

$36.70 / -0.125 (-0.34%)

ST
CARR

ST Sensata

$48.82 / -0.235 (-0.48%)

10/22/20 Barclays: Sensata price target raised to $55 from $49 at Barclays

10/19/20 Baird: Sensata initiated with an Outperform at Baird

10/06/20 Berenberg: Sensata initiated with a Buy at Berenberg

10/05/20: Fly Intel: Top five analyst upgrades

CARR Carrier Global

$36.70 / -0.125 (-0.34%)

11/30/20 Barclays: Carrier Global price target raised to $45 from $38 at Barclays

11/18/20 KeyBanc: Carrier Global price target raised to $47 from $42 at KeyBanc

10/15/20 Stephens: Carrier Global initiated with an Overweight at Stephens

10/13/20: Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Periodicals	Alibaba's Jack Ma makes first appearance since criticizing China, NYT says » 06:11 01/20/21 01/20 06:11 01/20/21 06:11 BABA Alibaba $251.70 / +8.29 (+3.41%) Alibaba Jack Ma has made… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BABA Alibaba $251.70 / +8.29 (+3.41%) 01/08/21 Bill Miller sees little impact on Alibaba cash flow from regulation 01/08/21 Alibaba recent pullback offers buying opportunity, Bill Miller says 01/08/21 Alibaba, Tencent not on Treasury's updated 'Chinese Military Companies' list 01/08/21 Alibaba, Tencent rally after updated Treasury ban list omits them BABA Alibaba $251.70 / +8.29 (+3.41%) 01/13/21 Mizuho Alibaba price target lowered to $270 from $300 at Mizuho 01/11/21 Macquarie Alibaba price target lowered to $387 from $394 at Macquarie 01/08/21 Mizuho Alibaba price target lowered to $300 from $325 at Mizuho 12/29/20 Truist Truist lowers Alibaba SOTP valuation but believes that break-up is unlikely BABA Alibaba $251.70 / +8.29 (+3.41%) 11/05/20 Alibaba reports Q2 adjusted EPS $2.65, consensus $2.11 11/04/20 Notable companies reporting before tomorrow's open 11/04/20 Notable companies reporting before tomorrow's open 08/20/20 Alibaba reports Q1 adjusted EPS $2.10, consensus $1.99 BABA Alibaba $251.70 / +8.29 (+3.41%) 01/13/21 Americans to still be able to invest in Chinese tech giants, WSJ reports 01/07/21 Ant Group plans to restructure consumer credit operations, Bloomberg reports 01/06/21 U.S. weighs adding Alibaba, Tencent to China investment blacklist, WSJ reports 01/05/21 Trump orders ban on transactions with 8 Chinese apps, incl. Alipay, Reuters says BABA Alibaba $251.70 / +8.29 (+3.41%) 01/09/21 Week in review: How Trump's policies moved stocks 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 12/28/20 Fly Intel: Wall Street's top stories for Monday 12/28/20 Fly Intel: Pre-market Movers 02/02/21 Alibaba - BABA BABA Alibaba $251.70 / +8.29 (+3.41%) 01/08/21 Notable open interest changes for January 8th 12/31/20 Notable open interest changes for December 31st 12/30/20 Unusually active option classes on open December 30th 12/30/20 Notable open interest changes for December 30th
Upgrade	Domtar upgraded to Buy from Neutral at BofA » 06:10 01/20/21 01/20 06:10 01/20/21 06:10 UFS Domtar / + BofA analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events UFS Domtar / + 01/08/21 Domtar to sell personal care business to American Industrial Partners for $920M 10/28/20 Domtar, Voith enter agreement to convert paper machine to produce containerboard 09/17/20 Domtar up 5% after report says Ontex weighing personal care unit bid 08/07/20 Domtar rises 18.5% UFS Domtar / + 06:02 Today BofA Domtar upgraded to Buy from Neutral at BofA 01/08/21 RBC Capital Domtar a more attractive acquisition target after unit sale, says RBC Capital 01/08/21 Citi Domtar more likely takeover target after unit sale, says Citi 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens UFS Domtar / + 11/06/20 Domtar reports Q3 adjusted EPS 33c, consensus (24c) 08/07/20 Domtar reports Q2 EPS ex-items 36c, consensus (48c) UFS Domtar / + 09/18/20 Belgium-based Ontex looks to buy Domtar's personal-care unit, Bloomberg reports 09/17/20 Ontex considering bid for Domtar's personal care business, Bloomberg says 02/11/21 Domtar - UFS
Recommendations	Pacira price target raised to $90 from $65 at Piper Sandler » 06:10 01/20/21 01/20 06:10 01/20/21 06:10 PCRX Pacira $73.91 / +0.23 (+0.31%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PCRX Pacira $73.91 / +0.23 (+0.31%) 12/09/20 Pacira reports preliminary November net product sales $38.9M 11/18/20 Pacira receives European Commission approval for EXPAREL 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 11/11/20 Pacira reports preliminary October net product sales $41.7M PCRX Pacira $73.91 / +0.23 (+0.31%) 01/06/21 RBC Capital Pacira price target raised to $70 at RBC Capital, named one of 2021 top ideas 12/14/20 Barclays Pacira price target raised to $79 from $73 at Barclays 09/30/20 Jefferies Pacira price target raised to $75 from $69 at Jefferies 09/21/20 Northland Pacira upgraded to Outperform on Exparel sales expectations at Northland PCRX Pacira $73.91 / +0.23 (+0.31%) 01/07/21 Pacira reports 2020 revenue $429.6M, consensus $427.7M 10/29/20 Pacira reports Q3 adj. EPS 68c, consensus 63c 10/07/20 Pacira reports preliminary Q3 net product sales of $116.9M, consensus $111.86M 08/06/20 Pacira reports preliminary July sales of Exparel of $38.1M 03/22/21 PDUFA Date for EXPAREL
Syndicate	TCR2 Therapeutics 4.59M share Secondary priced at $30.50 » 06:09 01/20/21 01/20 06:09 01/20/21 06:09 TCRR TCR2 Therapeutics $31.64 / -1.22 (-3.71%) The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate TCRR TCR2 Therapeutics $31.64 / -1.22 (-3.71%) 01/08/21 TCR2 Therapeutics announces 2021 strategic priorities, milestones 12/13/20 TCR2 announces interim data from ongoing Phase 1 of TC-210 Phase 1/2 trial 12/11/20 TCR2 Therapeutics to announce TC-210 interim data 11/10/20 TCR2 Therapeutics partners with ElevateBio to expand TC-210 capacity TCRR TCR2 Therapeutics $31.64 / -1.22 (-3.71%) 12/22/20 Mizuho Autolus, Arcus among top 2021 oncology picks at Mizuho 12/15/20 Mizuho TCR2 Therapeutics price target raised to $58 from $33 at Mizuho 12/14/20 Piper Sandler TCR2 Therapeutics price target raised to $45 from $35 at Piper Sandler 12/14/20 BMO Capital TCR2 Therapeutics price target raised to $65 from $46 at BMO Capital TCRR TCR2 Therapeutics $31.64 / -1.22 (-3.71%) 11/12/20 TCR2 Therapeutics reports Q3 EPS (56c), consensus (53c) 08/12/20 TCR2 Therapeutics reports Q2 EPS (67c), consensus (64c) 20 Jan 29 Jul
Periodicals	Pfizer/BioNTech vaccine likely to be effective against Covid variant, FT reports » 06:09 01/20/21 01/20 06:09 01/20/21 06:09 PFE Pfizer $36.74 / +0.03 (+0.08%) , BNTX BioNTech $104.98 / +3.435 (+3.38%) The Pfizer (PFE)/BioNTech… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/14/21 Pfizer says FDA approves supplemental NDA for Xalkori 01/14/21 Oragenics issues letter to stockholders on Terra CoV-2 01/13/21 Siga Technologies: Meridian Medical to purchase up to $33M of oral TPOXX 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/12/21 Canada orders 20M more doses of Pfizer, BioNTech Covid vaccine 01/08/21 Pfizer, BioNTech COVID vaccine elicits antibodies that neutralize mutation 01/07/21 BioNTech reports publication of preclinical data on novel mRNA vaccine approach 01/04/21 FDA continues to recommend authorized COVID vaccine dosing schedule PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $104.98 / +3.435 (+3.38%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate 23 Jul 06 Feb PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/18/21 NY Gov. asks Pfizer to directly sell COVID vaccine doses, Reuters reports 01/12/21 Pfizer, health officials investigating post-vaccine fatality, Bloomberg says 01/11/21 Pfizer says HHS would need to approve direct sales of COVID vaccine, CNBC says 01/04/21 Pfizer, BioNTech offered South Africa discounted vaccines, Bloomberg says BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/04/21 Pfizer, BioNTech offered South Africa discounted vaccines, Bloomberg says 12/30/20 Nurse tests positive for COVID-19 week after getting Pfizer vaccine, KGTV says 12/22/20 White House, Pfizer near deal for tens of millions of vaccine doses, WP says 12/21/20 NIAID to study allergic reactions from Pfizer's coronavirus shot, CNBC says PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 01/24/21 PDUFA Date for Xalkori (Crizotinib) - January 2021 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX PFE Pfizer $36.74 / +0.03 (+0.08%) 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th 12/11/20 Notable open interest changes for December 11th BNTX BioNTech $104.98 / +3.435 (+3.38%) 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th 11/02/20 Largest borrow rate increases among liquid names

Recommendations	Funko price target raised to $14 from $12 at Piper Sandler » 06:09 01/20/21 01/20 06:09 01/20/21 06:09 FNKO Funko $11.52 / -0.52 (-4.32%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly FNKO Funko $11.52 / -0.52 (-4.32%) 01/12/21 ChizComm Beacon Media announces contract with Funko FNKO Funko $11.52 / -0.52 (-4.32%) 12/04/20 Fly Intel: Top five analyst upgrades 12/04/20 Piper Sandler Funko upgraded to Overweight from Neutral at Piper Sandler 12/03/20 Fly Intel: Top five analyst downgrades 12/03/20 BMO Capital Funko downgraded to Underperform from Market Perform at BMO Capital FNKO Funko $11.52 / -0.52 (-4.32%) 11/05/20 Funko expects COVID-19 to continue impacting sales in Q4 11/05/20 Funko reports Q3 EPS 27c, consensus 10c 08/06/20 Funko reports Q2 EPS (30c), consensus (41c) FNKO Funko $11.52 / -0.52 (-4.32%) 08/07/20 Fly Intel: Wall Street's top stories for Friday 08/07/20 Fly Intel: Wall Street's top stories at midday
Downgrade	e.l.f. Beauty downgraded to Neutral from Overweight at Piper Sandler » 06:07 01/20/21 01/20 06:07 01/20/21 06:07 ELF e.l.f. Beauty $24.02 / +0.575 (+2.45%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ELF e.l.f. Beauty $24.02 / +0.575 (+2.45%) 01/07/21 e.l.f. Beauty to replace Brooks Automation in the S&P 600 at open on January 7 01/04/21 e.l.f. Beauty CEO sells 200.1K shares of common stock 12/31/20 e.l.f. Beauty rises 10.9% 12/30/20 e.l.f. Beauty to replace Brooks Automation in the S&P 600 at open on January 7 ELF e.l.f. Beauty $24.02 / +0.575 (+2.45%) 10/06/20 Piper Sandler Piper teen survey shows Snap, Amazon and Apple remain favorites 08/06/20 Truist e.l.f. Beauty price target raised to $25 from $20 at Truist 07/16/20 JPMorgan e.l.f. Beauty price target raised to $22 from $17 at JPMorgan 07/15/20 Piper Sandler e.l.f. Beauty price target raised to $25 from $20 at Piper Sandler ELF e.l.f. Beauty $24.02 / +0.575 (+2.45%) 11/04/20 e.l.f. Beauty sees FY22-FY24 net sales up mid-high single digits 11/04/20 e.l.f. Beauty sees FY21 EPS 59c-63c, consensus 66c 11/04/20 e.l.f. Beauty reports Q2 EPS 16c, consensus 13c 11/04/20 Notable companies reporting after market close ELF e.l.f. Beauty $24.02 / +0.575 (+2.45%) 12/30/20 Fly Intel: After-Hours Movers 11/04/20 Fly Intel: After-Hours Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 08/06/20 Fly Intel: Pre-market Movers
Syndicate	Fulcrum Therapeutics 4M share Spot Secondary priced at $11.00 » 06:07 01/20/21 01/20 06:07 01/20/21 06:07 FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) SVB Leerink, Piper… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 12/14/20 X4 Pharmaceuticals appoints Diego Cadavid as CMO 12/09/20 Fulcrum Therapeutics to host KOL event on FTX-6058 for sickle cell disease 12/06/20 Fulcrum Therapeutics presents updated data on SCD program 11/10/20 Fulcrum Therapeutics: Curtis Oltmans to join as general counsel FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 10/15/20 Piper Sandler Fulcrum Therapeutics initiated with an Overweight at Piper Sandler 08/12/20 Fly Intel: Top five analyst downgrades 08/12/20 BTIG Fulcrum Therapeutics price target lowered to $22 from $27 at BTIG 08/12/20 Morgan Stanley Fulcrum Therapeutics downgraded at Morgan Stanley, price target slashed to $11 FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 11/10/20 Fulcrum Therapeutics reports Q3 EPS (70c), consensus (65c) 08/11/20 Fulcrum Therapeutics reports Q2 EPS (66c), consensus (78c) 20 Jan FULC Fulcrum Therapeutics $11.77 / +0.83 (+7.59%) 08/11/20 Fly Intel: Wall Street's top stories for Tuesday 08/11/20 Fly Intel: Wall Street's top stories at midday
Initiation	Zscaler initiated with an Outperform at JMP Securities » 06:07 01/20/21 01/20 06:07 01/20/21 06:07 ZS Zscaler $212.00 / +0.66 (+0.31%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options ZS Zscaler $212.00 / +0.66 (+0.31%) 12/23/20 Zscaler launches security assessment program following SolarWinds attack 11/12/20 Zscaler appoints Chris Kozup as CMO 09/30/20 Zscaler director sells 20K shares of common stock 09/29/20 JFrog appoints Micheline Nijmeh as chief marketing officer ZS Zscaler $212.00 / +0.66 (+0.31%) 01/12/21 Needham Zscaler price target raised to $240 from $215 at Needham 01/12/21 Credit Suisse Zscaler price target raised to $215 from $175 at Credit Suisse 01/12/21 Baird Zscaler price target raised to $220 from $180 at Baird 01/12/21 Truist Zscaler price target raised to $175 from $130 at Truist ZS Zscaler $212.00 / +0.66 (+0.31%) 12/03/20 Zscaler raises FY21 EPS view to 37c-38c from 28c-30c, consensus 31c 12/02/20 Zscaler sees Q2 EPS 7c-8c, consensus 7c 12/02/20 Zscaler reports Q1 EPS 14c, consensus 6c 12/02/20 Notable companies reporting after market close ZS Zscaler $212.00 / +0.66 (+0.31%) 09/01/20 Hackers test security of Trump campaign sites ahead of election, Reuters says ZS Zscaler $212.00 / +0.66 (+0.31%) 12/23/20 Qualcomm initiation, IAC downgrade among today's top calls on Wall Street 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack 12/03/20 Fly Intel: Wall Street's top stories for Thursday 12/03/20 Fly Intel: Wall Street's top stories at midday ZS Zscaler $212.00 / +0.66 (+0.31%) 12/07/20 Zscaler put volume heavy and directionally bearish 12/04/20 Unusually active option classes on open December 4th 12/02/20 Zscaler options imply 13.7% move in share price post-earnings 09/17/20 Zscaler put volume heavy and directionally bearish
Syndicate	Syros Pharmaceuticals 5.4M share Spot Secondary priced at $14.00 » 06:06 01/20/21 01/20 06:06 01/20/21 06:06 SYRS Syros Pharmaceuticals $14.99 / +0.88 (+6.24%) Cowen and Piper Sandler… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SYRS Syros Pharmaceuticals $14.99 / +0.88 (+6.24%) 12/06/20 Syros acquires clinical-stage drug candidate for Acute Promyelocytic Leukemia 12/06/20 Syros Pharmaceuticals presents new data from Phase 2 trial of SY-1425 11/04/20 Syros to present new data from Phase 2 SY-1425 trial at ASH meeting 10/25/20 Syros presents initial data from Phase 1 trial of SY-5609 SYRS Syros Pharmaceuticals $14.99 / +0.88 (+6.24%) 11/10/20 Brookline Syros Pharmaceuticals initiated with a Buy at Brookline 11/05/20 Roth Capital Syros' SY-1425+Aza could be competitive in multiple settings, says Roth Capital 11/04/20 Fly Intel: Top five analyst upgrades 11/04/20 H.C. Wainwright Syros Pharmaceuticals upgraded to Buy from Neutral at H.C. Wainwright SYRS Syros Pharmaceuticals $14.99 / +0.88 (+6.24%) 11/05/20 Syros Pharmaceuticals reports Q3 EPS (43c), consensus (38c) 08/06/20 Syros Pharmaceuticals reports Q2 EPS (38c), consensus (40c) 20 Jan SYRS Syros Pharmaceuticals $14.99 / +0.88 (+6.24%) 01/19/21 Fly Intel: After-Hours Movers 01/07/21 Fly Intel: After-Hours Movers

Upgrade	Northland Power upgraded to Outperform from Neutral at Credit Suisse » 06:06 01/20/21 01/20 06:06 01/20/21 06:06 NPIFF Northland Power / + Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research NPIFF Northland Power / + 01/13/21 CIBC Northland Power downgraded to Neutral from Outperformer at CIBC 01/06/21 National Bank Northland Power price target raised to C$50 from C$45 at National Bank 01/06/21 National Bank Northland Power upgraded to Outperform from Sector Perform at National Bank 11/12/20 CIBC Northland Power price target raised to C$45 from C$44 at CIBC
Initiation	SenesTech initiated with a Buy at H.C. Wainwright » 06:06 01/20/21 01/20 06:06 01/20/21 06:06 SNES SenesTech $2.13 / +0.08 (+3.90%) H.C. Wainwright analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News SNES SenesTech $2.13 / +0.08 (+3.90%) 09/30/20 SenesTech provides update on impact of California ecosystems protection act 09/28/20 SenesTech's ContraPest added to San Francisco reduced risk pesticide list 09/02/20 SenesTech: CA's AB1788 passed by legislature, sent to Governor
Periodicals	Google probes actions of ethical AI leader Margaret Mitchell, Axios reports » 06:05 01/20/21 01/20 06:05 01/20/21 06:05 GOOG Alphabet $1,790.48 / +54.11 (+3.12%) , GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) Google is investigating… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GOOG GOOGL GOOG Alphabet $1,790.48 / +54.11 (+3.12%) 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy 01/14/21 Abbott launches NeuroSphere myPath digital health app GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) 01/19/21 Google Cloud launches Product Discovery Solutions for Retail 01/17/21 Fly Intel: Top five weekend stock stories 01/14/21 Google completes acquisition of Fitbit, commits to protect users' privacy 01/14/21 Abbott launches NeuroSphere myPath digital health app GOOG GOOGL GOOG Alphabet $1,790.48 / +54.11 (+3.12%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson 01/12/21 Cowen Alphabet price target raised to $2200 from $1900 at Cowen 01/11/21 Jefferies Yelp downgraded to Hold on 'full' valuation at Jefferies GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) 01/19/21 JPMorgan JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration' 01/19/21 KeyBanc Alphabet price target to $2,060 from $1,970 at KeyBanc 01/15/21 MoffettNathanson Alphabet price target raised to $2,100 from $1,900 at MoffettNathanson 01/11/21 Jefferies Yelp downgraded to Hold on 'full' valuation at Jefferies GOOG GOOGL GOOG Alphabet $1,790.48 / +54.11 (+3.12%) 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago 10/29/20 Alphabet reports Q3 EPS $16.40, consensus $11.29 GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) 10/29/20 Alphabet CFO sees signs user behavior beginning to return to normalized level 10/29/20 Alphabet reports Q3 Traffic Acquisition Costs $8.17B vs. $7.49B a year ago 10/29/20 Alphabet reports Q3 Google Cloud revenue $3.44B vs. $2.38B a year ago 10/29/20 Alphabet reports Q3 Google advertising revenue $37.1B vs. $33.8B a year ago GOOG GOOGL GOOG Alphabet $1,790.48 / +54.11 (+3.12%) 01/19/21 YouTube extends Trump channel ban for extra week, CNBC says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/14/21 Apple pulls social media platform Wimkin from App Store, WSJ reports 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) 01/19/21 YouTube extends Trump channel ban for extra week, CNBC says 01/17/21 Google might face 4th government suit over business practices, Reuters says 01/14/21 Apple pulls social media platform Wimkin from App Store, WSJ reports 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports GOOG GOOGL GOOG Alphabet $1,790.48 / +54.11 (+3.12%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 01/13/21 #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 00:00 Today Technology 02/02/21 Alphabet Class A - GOOGL 02/02/21 Alphabet - GOOG GOOG GOOGL GOOG Alphabet $1,790.48 / +54.11 (+3.12%) 11/10/20 Alphabet call volume above normal and directionally bullish 10/30/20 Early notable gainers among liquid option names on October 30th GOOGL Alphabet Class A $1,784.39 / +56.98 (+3.30%) 10/30/20 Early notable gainers among liquid option names on October 30th 10/21/20 Unusually active option classes on open October 21st 08/27/20 Alphabet Class A call volume above normal and directionally bullish
Upgrade	Aveva upgraded to Buy from Hold at Berenberg » 06:04 01/20/21 01/20 06:04 01/20/21 06:04 AVEVF Aveva $0.00 / + (+0.00%) Berenberg analyst Gal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events AVEVF Aveva $0.00 / + (+0.00%) 08/25/20 Aveva to acquire OSIsoft for $5B AVEVF Aveva $0.00 / + (+0.00%) 01/05/21 UBS Aveva upgraded to Buy from Neutral at UBS 01/04/21 Investec Aveva upgraded to Buy from Hold at Investec 12/11/20 Credit Suisse Aveva price target lowered to 3,620 GBp from 4,690 GBp at Credit Suisse 12/03/20 UBS Aveva price target lowered to 3,500 GBp from 3,574 GBp at UBS 02/11/21 Technology & Internet Virtual Conference
Earnings	UnitedHealth backs FY21 adjusted EPS view $17.75-$18.25, consensus $18.18 » 06:03 01/20/21 01/20 06:03 01/20/21 06:03 UNH UnitedHealth $352.10 / +0.995 (+0.28%) Backs FY21 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options UNH UnitedHealth $352.10 / +0.995 (+0.28%) 01/14/21 Teladoc down 2% pre-market as UnitedHealth debuts virtual primary care offering 01/14/21 UnitedHealth announces expanded access to virtual care, new primary care service 01/06/21 Change Healthcare jumps 37% to $25.10 after agreeing to merge with UnitedHealth 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash UNH UnitedHealth $352.10 / +0.995 (+0.28%) 01/07/21 Wells Fargo Change Healthcare downgraded to Equal Weight from Overweight at Wells Fargo 01/07/21 Cowen Change Healthcare downgraded to Market Perform from Outperform at Cowen 01/07/21 Deutsche Bank UnitedHealth price target raised to $404 from $359 at Deutsche Bank 01/07/21 RBC Capital Change Healthcare downgraded to Sector Perform from Outperform at RBC Capital UNH UnitedHealth $352.10 / +0.995 (+0.28%) 05:59 Today UnitedHealth reports Q4 adjusted EPS $2.52, consensus $2.41 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 12/01/20 UnitedHealth sees FY21 adjusted EPS $17.75-$18.25, consensus $18.33 UNH UnitedHealth $352.10 / +0.995 (+0.28%) 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports 11/10/20 Supreme Court appears unlikely to topple ACA, USA Today says 10/01/20 Insurers reduce coverage for virtual doctors' visits, WSJ reports 09/29/20 UnitedHealth buys DivvyDose, a rival of Amazon's PillPack, CNBC says UNH UnitedHealth $352.10 / +0.995 (+0.28%) 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 01/06/21 Fly Intel: Pre-market Movers 12/01/20 Fly Intel: Wall Street's top stories for Tuesday 08:45 Today UnitedHealth - UNH UNH UnitedHealth $352.10 / +0.995 (+0.28%) 10/14/20 Unusually active option classes on open October 14th

Upgrade	Domtar upgraded to Buy from Neutral at BofA » 06:02 01/20/21 01/20 06:02 01/20/21 06:02 UFS Domtar $32.65 / +1.29 (+4.11%) BofA analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events UFS Domtar $32.65 / +1.29 (+4.11%) 01/08/21 Domtar to sell personal care business to American Industrial Partners for $920M 10/28/20 Domtar, Voith enter agreement to convert paper machine to produce containerboard 09/17/20 Domtar up 5% after report says Ontex weighing personal care unit bid 08/07/20 Domtar rises 18.5% UFS Domtar $32.65 / +1.29 (+4.11%) 01/08/21 RBC Capital Domtar a more attractive acquisition target after unit sale, says RBC Capital 01/08/21 Citi Domtar more likely takeover target after unit sale, says Citi 01/04/21 Stephens Brinker, LiveRamp and Vonage among 2021 best ideas at Stephens 12/18/20 CIBC Domtar upgraded to Neutral from Underperformer at CIBC UFS Domtar $32.65 / +1.29 (+4.11%) 11/06/20 Domtar reports Q3 adjusted EPS 33c, consensus (24c) 08/07/20 Domtar reports Q2 EPS ex-items 36c, consensus (48c) UFS Domtar $32.65 / +1.29 (+4.11%) 09/18/20 Belgium-based Ontex looks to buy Domtar's personal-care unit, Bloomberg reports 09/17/20 Ontex considering bid for Domtar's personal care business, Bloomberg says 02/11/21 Domtar - UFS
Hot Stocks	Aptorum Group's Phase 1 ALS-4 trial receives clearance from Health Canada » 06:02 01/20/21 01/20 06:02 01/20/21 06:02 APM Aptorum Group $3.17 / -0.11 (-3.35%) Aptorum Group, through… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly APM Aptorum Group $3.17 / -0.11 (-3.35%) 12/21/20 Aptorum Group submits CTA to Health Canada to conduct Phase 1 trial of ALS-4 09/29/20 Aptorum Group launches infectious disease liquid biopsy subsidiary APM Aptorum Group $3.17 / -0.11 (-3.35%) 07/13/20 Alliance Global Partners Aptorum Group initiated with a Buy at Alliance Global Partners APM Aptorum Group $3.17 / -0.11 (-3.35%) 09/29/20 Fly Intel: Wall Street's top stories for Tuesday 09/29/20 Fly Intel: Wall Street's top stories at midday 09/29/20 Fly Intel: Pre-market Movers
Hot Stocks	Commerce Bancshares reports Q4 return on average assets of 1.63% » 06:02 01/20/21 01/20 06:02 01/20/21 06:02 CBSH Commerce Bancshares $71.07 / +0.69 (+0.98%) For the quarter, the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings CBSH Commerce Bancshares $71.07 / +0.69 (+0.98%) 10/21/20 Raymond James Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James 10/21/20 BofA Commerce Bancshares upgraded to Neutral from Underperform at BofA 10/21/20 Raymond James Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James 10/21/20 BofA Commerce Bancshares upgraded to Neutral from Underperform at BofA CBSH Commerce Bancshares $71.07 / +0.69 (+0.98%) 06:00 Today Commerce Bancshares reports Q4 EPS $1.11, consensus 94c 10/20/20 Commerce Bancshares reports Q3 EPS $1.11, consensus 7c 07/21/20 Commerce Bancshares reports Q2 EPS 34c, consensus 53c 07/21/20 Commerce Bancshares reports Q2 EPS 34c, consensus 53c
Earnings	Commerce Bancshares reports Q4 EPS $1.11, consensus 94c » 06:00 01/20/21 01/20 06:00 01/20/21 06:00 CBSH Commerce Bancshares $71.07 / +0.69 (+0.98%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings CBSH Commerce Bancshares $71.07 / +0.69 (+0.98%) 10/21/20 Raymond James Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James 10/21/20 BofA Commerce Bancshares upgraded to Neutral from Underperform at BofA 10/21/20 Raymond James Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James 10/21/20 BofA Commerce Bancshares upgraded to Neutral from Underperform at BofA CBSH Commerce Bancshares $71.07 / +0.69 (+0.98%) 10/20/20 Commerce Bancshares reports Q3 EPS $1.11, consensus 7c 07/21/20 Commerce Bancshares reports Q2 EPS 34c, consensus 53c 07/21/20 Commerce Bancshares reports Q2 EPS 34c, consensus 53c
Initiation	Innergex Renewable Energy initiated with a Neutral at Credit Suisse » 06:00 01/20/21 01/20 06:00 01/20/21 06:00 INGXF Innergex Renewable Energy / + Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research INGXF Innergex Renewable Energy / + 01/13/21 CIBC Innergex Renewable Energy price target raised to C$32 from C$26 at CIBC 01/06/21 National Bank Innergex Renewable price target raised to C$32 from C$27 at National Bank 11/13/20 RBC Capital Innergex Renewable Energy price target raised to C$25 from C$23 at RBC Capital 11/12/20 CIBC Innergex Renewable Energy price target lowered to C$26 from C$26.50 at CIBC

Downgrade	American Homes 4 Rent downgraded to In Line from Outperform at Evercore ISI » 06:00 01/20/21 01/20 06:00 01/20/21 06:00 AMH American Homes 4 Rent $30.45 / +0.25 (+0.83%) Evercore ISI analyst Rich… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly AMH American Homes 4 Rent $30.45 / +0.25 (+0.83%) 11/12/20 American Homes 4 Rent acquires 55 acres in Georgia, invests $50M to develop 07/28/20 American Homes 4 Rent introduces Spring Rose community in Florida AMH American Homes 4 Rent $30.45 / +0.25 (+0.83%) 01/07/21 B. Riley Securities American Homes 4 Rent transferred with Buy rating at B. Riley Securities 12/15/20 Citi American Homes 4 Rent price target raised to $31 from $28 at Citi 12/10/20 Fly Intel: Top five analyst upgrades 12/10/20 Wells Fargo American Homes 4 Rent upgraded to Overweight at Wells Fargo AMH American Homes 4 Rent $30.45 / +0.25 (+0.83%) 11/05/20 American Homes 4 Rent reports Q3 core FFO 29c, consensus 28c 08/06/20 American Homes 4 Rent reports Q2 core FFO 27c , consensus 27c 18 Aug AMH American Homes 4 Rent $30.45 / +0.25 (+0.83%) 08/17/20 Fly Intel: After-Hours Movers
Downgrade	Invitation Homes downgraded to In Line from Outperform at Evercore ISI » 06:00 01/20/21 01/20 06:00 01/20/21 06:00 INVH Invitation Homes $29.45 / -0.13 (-0.44%) Evercore ISI analyst Rich… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events INVH Invitation Homes $29.45 / -0.13 (-0.44%) 10/07/20 Invitation Homes enters $375M JV with Rockpoint Group 09/15/20 Invitation Homes chairman sells 50,000 common shares 08/18/20 Invitation Homes CEO sells 80K shares of common stock 08/03/20 Invitation Homes resumed placing acquisitions under contract in June INVH Invitation Homes $29.45 / -0.13 (-0.44%) 01/07/21 B. Riley Securities Invitation Homes transferred with Buy rating at B. Riley Securities 12/15/20 Citi Invitation Homes price target raised to $34 from $32 at Citi 12/07/20 BofA Broadcom added to US 1 List, Invitation Homes removed at BofA 11/06/20 B. Riley Securities Invitation Homes price target raised to $33 from $30 at B. Riley Securities INVH Invitation Homes $29.45 / -0.13 (-0.44%) 10/28/20 Invitation Homes reports Q3 core FFO 30c, consensus 31c 08/03/20 Invitation Homes reports Q2 EPS 8c, consensus 6c 02 Jun 02/17/21 Invitation Homes - INVH
Downgrade	UDR downgraded to In Line from Outperform at Evercore ISI » 05:59 01/20/21 01/20 05:59 01/20/21 05:59 UDR UDR $38.68 / -0.72 (-1.83%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options UDR UDR $38.68 / -0.72 (-1.83%) 01/19/21 UDR CEO sells 120K shares of common stock 01/06/21 UDR CEO sells 100,000 common shares 12/16/20 UDR announces COO Jerry Davis to transition out of role, executive promotions 10/12/20 UDR appoints CyrusOne CFO Diane Morefield to its board UDR UDR $38.68 / -0.72 (-1.83%) 01/11/21 BMO Capital UDR upgraded to Outperform from Market Perform at BMO Capital 12/15/20 Citi UDR price target raised to $39 from $38 at Citi 11/20/20 Morgan Stanley UDR upgraded to Overweight amid 'green shoots' at Morgan Stanley 11/20/20 Morgan Stanley UDR upgraded to Overweight from Equal Weight at Morgan Stanley UDR UDR $38.68 / -0.72 (-1.83%) 10/29/20 UDR sees Q4 AFFO 43c-45c, consensus 51c 10/29/20 UDR reports Q3 adjusted FFO 45c, consensus 50c 07/28/20 UDR reports Q2 AFFO 47c, consensus 53c 02/10/21 UDR - UDR UDR UDR $38.68 / -0.72 (-1.83%) 12/02/20 Early notable gainers among liquid option names on December 2nd
Upgrade	Essex Property Trust upgraded to Outperform from In Line at Evercore ISI » 05:59 01/20/21 01/20 05:59 01/20/21 05:59 ESS Essex Property Trust $237.14 / -3.29 (-1.37%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ESS Essex Property Trust $237.14 / -3.29 (-1.37%) 12/28/20 Essex Property Trust COO John Burkart to retire ESS Essex Property Trust $237.14 / -3.29 (-1.37%) 12/15/20 Citi Essex Property Trust price target raised to $250 from $235 at Citi 12/03/20 BMO Capital Essex Property upgraded to Market Perform from Underperform at BMO Capital 11/20/20 Morgan Stanley Essex Property Trust price target raised to $279 from $215 at Morgan Stanley 11/12/20 BTIG Essex Property Trust upgraded to Buy from Neutral at BTIG ESS Essex Property Trust $237.14 / -3.29 (-1.37%) 10/28/20 Essex Property Trust reports Q3 core FFO $3.15, consensus $3.16 08/03/20 Essex Property Trust reports Q2 core FFO $3.16, consensus $3.30 02/05/21 Essex Property Trust - ESS
Initiation	Penn National initiated with an Outperform at Credit Suisse » 05:59 01/20/21 01/20 05:59 01/20/21 05:59 PENN Penn National / + Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PENN Penn National / + 01/19/21 Penn National announces online sports wagering approval in Michigan 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M 01/13/21 Choice Hotels announces loyalty program agreement with Penn National Gaming 01/06/21 New York seeking proposals for mobile sports wagering operator PENN Penn National / + 01/14/21 Fly Intel: Top five analyst downgrades 01/14/21 Truist Penn National price target raised to $120 from $85 at Truist 01/14/21 Craig-Hallum Dec. NJ gaming data caps off year of significant growth, says Craig-Hallum 01/14/21 KeyBanc Penn National initiated with a Sector Weight at KeyBanc on 'lofty assumptions' PENN Penn National / + 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 08/06/20 Penn National reports Q2 EPS ($1.69), consensus ($2.11) 25 Sep 12 May PENN Penn National / + 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 01/08/21 Las Vegas Sands could shift strategy towards sports betting, Bloomberg says 01/08/21 Las Vegas Sands in talks for online sports betting, Bloomberg reports 01/06/21 Cuomo to add mobile sports betting to policy proposals, NY Daily News says PENN Penn National / + 01/15/21 Bet On It: New Jersey handle ranks highest in 2020 01/08/21 Bet On It: New York warming up to online sports betting 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 12/31/20 Bet On It: Rush Street Interactive completes SPAC merger, exceeds expectations 02/04/21 Penn National - PENN PENN Penn National / + 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish 12/08/20 Penn National call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

Today at 07:00

MBA Mortgage Applications: Composite Index W/W: 1/15/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Purchase Index W/W: 1/15/2021 Government Event
Today at 07:00

MBA Mortgage Applications: Refinance Index W/W: 1/15/2021 Government Event
CALT
Today at 07:00

Calliditas Therapeutics Firm Sponsored Meetings

Virtual Meeting
CFG
Today at 08:00

Citizens Financial - CFG Conference Calls
BK
Today at 08:00

BNY Mellon - BK Conference Calls
MESO
Today at 08:00

Mesoblast - MESO Conference Calls
Today at 08:00

Homebuilders Industry Meetings

Virtual Meeting
FNB
Today at 08:15

F.N.B. - FNB Conference Calls
MS
Today at 08:30

Morgan Stanley - MS Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright $3.17 4.167M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim $9.14 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel $22.00-23.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE $13.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Sensata signs strategic long-term agreement with Carrier Global

TODAY'S FREE FLY STORIES

Get Full Fly Access